U.S. Hotel and Resort REITs Stock News

PancakeSwap's listing of a token backed by USA Rare Earth (USAR) shares has put the stock in front of a different investor crowd, linking it to the growing market for tokenized equities. See our latest analysis for USA Rare Earth. USA Rare Earth’s recent 11.03% 1 day share price return and 29.30% 7 day share price return sit against a 90 day share price return that declined 28.30%, while the 3 year total shareholder return of 90.82% points to stronger longer term gains. If tokenization and...

Arhaus stock barely flinched after earnings, slipping less than 1% to about US$9.60, even though the headline numbers were anything but sleepy. Q2 net revenue reached about US$384.9m and basic earnings per share landed near US$0.28, solid figures for a premium home furnishings retailer that has already delivered a strong 90 day share price run. The real story sits on a longer horizon. Arhaus now carries a trailing P/E of 19.6x, slightly below specialty retail peers. A discounted cash flow...

Trade Desk stock just took a beating, closing at US$13.80 and erasing roughly 22% in a single session, even though the core ad tech engine is still producing profit. Q2 revenue came in at US$715 million and adjusted earnings before interest, tax, depreciation and amortization margin held at 34%. The real story is not today’s screen shock. It is how that margin profile, the 13.6% trailing net profit margin and a P/E of 15.9x compare with a long runway of digital ad spend and a valuation that...

Q2 2026 earnings spotlight for Recursion Pharmaceuticals Recursion Pharmaceuticals (RXRX) released its Q2 2026 results on 5 August, giving investors fresh data on revenue trends and ongoing losses as the company continues to invest in its drug discovery platform. The company reported second quarter sales of US$7.3 million and total revenue of US$7.67 million, compared with US$19.1 million and US$19.22 million in the same period last year. Net loss for the quarter was US$131.01 million with a...

EOG Resources (EOG) moved into focus after its Q2 2026 report showed revenue of US$8.62b and net income of US$2.72b, alongside production guidance and a reaffirmed regular dividend. See our latest analysis for EOG Resources. The latest earnings, production guidance and affirmed dividend came after a strong run, with EOG Resources posting a year to date share price return of 25.61% and a 1 year total shareholder return of 19.90%. However, shorter term momentum has faded, with the share price...

Fortinet stock has delivered a strong 167.5% return over the past three years, yet current valuation checks suggest the shares are trading at a premium to what the intrinsic value estimate and market multiples imply. Over the past three years, Fortinet has returned 167.5%, which puts extra focus on whether recent gains already reflect much of the good news in the price. Markets are currently weighing higher growth expectations from Fortinet's AI driven security products against the risk that...

Amer Sports (AS) is back in focus after recent commentary highlighted its history of topping earnings estimates and a current Earnings ESP of +15.69%, which has coincided with a positive shift in analyst sentiment. See our latest analysis for Amer Sports. Amer Sports shares recently closed at US$36.84, with a 30 day share price return of 8.74% and a year to date share price return that is down 1.76%, while the 1 year total shareholder return is down 0.97%. Taken together, these figures...

Insight Enterprises stock barely moved on the day, edging up just 0.1% to about $149 even as the company reported one of its punchiest earnings updates in years. The market reaction looked muted compared to a quarter anchored by adjusted diluted earnings per share of $3.86 and adjusted EBITDA of $190 million, both sharply ahead of recent run rate. For an information technology solutions stock that had already climbed over the past quarter, this flat performance suggests investors are still...

Progyny stock just took a nearly 7% hit, even though the quarter delivered what many investors say they want in a healthcare benefits company. Revenue reached about US$350.5m and basic earnings per share landed near US$0.36, both in line with a business that continues to translate fertility coverage demand into profit. The focus this quarter is on margin strength. Net income excluding one-offs came in around US$28.1m, and trailing twelve-month earnings and net margins remain higher than a...

MercadoLibre stock barely flinched after Q2, slipping about 0.5% to around US$1,820 even as headline numbers landed with real weight. Revenue reached roughly US$10.2b and basic earnings per share came in just above US$9. That muted price move sits against a longer backdrop where the stock has risen over the past three months and yet still trades on a rich trailing P/E near 50x. The key story is not the quarter’s beat or miss noise. It is a deliberate margin squeeze as MercadoLibre pours cash...

Abacus Global Management shares just dropped 8.6% in a single session, yet the latest quarter reads more like an execution win than a collapse in fundamentals. The stock comes into this print after a weak month and a flat few months overall, priced on a premium 32.8x trailing P/E that already assumes a lot. In that context, the real headline is profit quality. Adjusted net income of US$27.1m and a roughly 55% adjusted EBITDA margin landed strong, while a large one off loss in the trailing...

Corsair Gaming just saw its stock jump about 35% to roughly US$14.38, a sharp move for a mid cap gaming hardware company. That reaction hinges on one headline: Q2 brought record gross margin of 33.2% and US$30.8m in adjusted earnings before interest, tax, depreciation and amortisation, powered by high margin peripherals and strong operating cash flow of US$74.8m. Short term traders are chasing the print. Longer term investors are likely to focus on whether this margin and cash engine can hold...

Lantheus Holdings stock barely flinched after earnings, easing just 0.1% and leaving investors to wonder what exactly the market is reacting to. The calm price move sits against a quarter where revenue of about US$388 million met a high bar and earnings per share of roughly US$1.15 kept profit quality squarely in focus. The real tension sits in how investors interpret a solid trailing P/E of 23.9x against a medical imaging specialist that has already banked more than US$275 million of net...

CoreWeave (CRWV) is back in focus after IMC agreed to a significantly larger commitment for its AI cloud clusters, a client update that arrives as the stock trades near $90 with mixed recent returns. See our latest analysis for CoreWeave. CoreWeave’s recent client wins and expansion headlines have arrived alongside sharp price swings, with a 7 day share price return of 26.33% at US$90.67 but a 1 year total shareholder return that is down 30.01%. The mixed pattern of a 1 day share price return...

Inogen stock went into this report already under pressure, down over 13% in the past three months. The latest earnings knocked it another 6.8% lower to about US$6 a share. The market is trading this as a setback, yet the headline from the quarter tells a different story. Revenue reached US$95.1m and losses narrowed, with adjusted net income close to breakeven and positive free cash flow. The real flashpoint is the cut to full year revenue guidance. That single move appears to be driving most...

Onto Innovation stock ripped higher today, jumping about 15% after traders digested a Q2 report that focused attention back on the earnings power of its chip tools. The market reaction looks tied to one key message: this quarter was about margins. Onto Innovation reported gross margin of 57% and operating margin of 30%, strong numbers for a semiconductor equipment supplier and central to how investors think about long term cash generation. With management pointing to further margin expansion...

Ultragenyx Pharmaceutical stock has had a tough run over the past few years, yet current valuation checks do not frame it as an obvious bargain either. After a period of weak long term returns, the market now appears to be pricing Ultragenyx with a modestly expensive tilt based on standard multiples. Ultragenyx Pharmaceutical has declined 72.1% over the past 5 years, which raises the question of whether the share price now reflects the company’s progress or if sentiment has simply reset...

Match Group (MTCH) is in focus after second quarter results on August 4 showed net income of US$170.55 million on sales of US$853.11 million, alongside softer third quarter revenue guidance and fresh capital allocation moves. See our latest analysis for Match Group. Match Group's share price closed at US$37.26 on August 6, and the stock has risen 17.39% year to date, although the 5 year total shareholder return shows a decline of 71.52%. Short term momentum looks softer, with the 7 day share...

Traders rushed into Unusual Machines, pushing the stock up 7.6% to about $26 after the Q2 print, yet the numbers tell a more complicated story than a simple relief rally. The headline is a very large jump in revenue to about $16.7m while the company still reported a net loss of about $7.8m, or $0.16 per share. The emotional tug of explosive drone demand met the reality of a loss making business that is spending heavily to keep up. The real question for you is whether today’s enthusiasm...

Yelp stock barely flinched after earnings, ticking up about 2% to roughly where it started the week. For a local ads and reviews platform facing a soft ad market, the headline was not the share price. It was a rare mix of pressure and promise as net income for the quarter came in at US$32 million alongside revenue of US$375.5 million. The market’s restrained reaction looks like investors are still processing one key question. Is this profit squeeze a temporary hit from heavier AI and product...

Clean Energy Fuels came into this earnings season with a bruised stock, down almost 30% over the last month, and the latest report hit sentiment again. The share price dropped about 15% to roughly US$1.58 after the Q2 release, even though management called the quarter solid and kept full year adjusted EBITDA guidance at US$70 million to US$75 million. The gap here is not about revenue, which stood at US$106.4 million, or volumes, which grew modestly. The pressure point is profitability...

GE HealthCare Technologies (GEHC) is back in focus after unveiling the LOGIQ e laptop ultrasound family, along with its new Invenia ABUS Prime and ABUS StreamVue systems, all recently cleared by U.S. and European regulators. See our latest analysis for GE HealthCare Technologies. GE HealthCare Technologies has seen short term momentum pick up, with a 1 month share price return of 10.96% and a 3 month share price return of 13.08%. However, the year to date share price return is down 13.34% and...

Cerence stock barely flinched after earnings, ticking up about 1% to around US$9, even as the company finally put a clean profit on the board. For a software supplier that powers in car voice and artificial intelligence experiences, a US$1.5 million net income and US$20 million in free cash flow mark a clear break from its recent loss making stretch. The emotional tug of a long unprofitable history looks stronger than the numbers from this quarter. With revenue near US$70 million and a fresh...

JFrog stock jumped 7.9% to US$89.61 into the close, which indicates traders responded positively to the headline. The company exceeded the high end of its Q2 2026 guidance and raised full year revenue expectations, supported by software supply chain demand tied to artificial intelligence projects. The short term story is a clean beat and raise. The longer term question is whether fast growing cloud revenue and a 121% net dollar retention rate in the customer base are enough to support a stock...